Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Frontiers in Oncology|January 19, 2016
Cross-Talk between AURKA and Plk1 in Mitotic Entry and Spindle AssemblyItalia Anna Asteriti, Fabiola De Mattia, Giulia GuarguagliniOncotarget|August 26, 2014
The Aurora-A inhibitor MLN8237 affects multiple mitotic processes and induces dose-dependent mitotic abnormalities and aneuploidyItalia Anna Asteriti, Erica Di Cesare, Fabiola De Mattia, et al.Current Biology : CB|February 3, 2016
NuMA Phosphorylation by Aurora-A Orchestrates Spindle OrientationSara Gallini, Manuel Carminati, Fabiola De Mattia, et al.Scientific Reports|August 17, 2017
Biological and functional characterization of bone marrow-derived mesenchymal stromal cells from patients affected by primary immunodeficiencyNadia Starc, Daniela Ingo, Antonella Conforti, et al.Analytical Chemistry|January 11, 2020
Leukocyte and Dried Blood Spot Arylsulfatase A Assay by Tandem Mass SpectrometryXinying Hong, Arun Babu Kumar, Jessica Daiker, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|October 3, 2020
Hematopoietic Tumors in a Mouse Model of X-linked Chronic Granulomatous Disease after Lentiviral Vector-Mediated Gene TherapyRaisa Jofra Hernández, Andrea Calabria, Francesca Sanvito, et al.Nature|October 23, 2024
Long-term lineage commitment in haematopoietic stem cell gene therapyAndrea Calabria, Giulio Spinozzi, Daniela Cesana, et al.Lancet (London, England)|January 23, 2022
Lentiviral haematopoietic stem-cell gene therapy for early-onset metachromatic leukodystrophy: long-term results from a non-randomised, open-label, phase 1/2 trial and expanded accessFrancesca Fumagalli, Valeria Calbi, Maria Grazia Natali Sora, et al.The New England Journal of Medicine|April 23, 2025
Long-Term Effects of Atidarsagene Autotemcel for Metachromatic LeukodystrophyFrancesca Fumagalli, Valeria Calbi, Vera Gallo, et al.Pageof 1